GENOMIND, INC.
Pharmacogenetic testing and interpretation platform with patient-facing reports and real-time symptom tracking for psychiatric medication selection
- Sector
- Medtech
- Headquarters
- KING OF PRUSSIA, PA
- Founded
- 2014
- Latest Form D
- $4.9M, Dec 2020
- Total capital
- $14.3M
- Federal grants
- $400K
- 1 award · 2023
- Rank in peer group#32 of 116
- Private capital raised
- $13.9M
- 4 Form D · last Dec 2020
- 71 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 16 pending · first 2023
- Rank in peer group#38 of 116
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of a Patient-Facing Portal for the Receipt, Interpretation and Tracking Utility of Pharmacogenetic (PGx) Data$400K
- Private capital raisedForm D · SEC · 4th filing$4.9M
- Private capital raisedForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$6.3M
- Private capital raisedForm D · SEC · 1st filing$2.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 116 peers
Line = medianMedtech · Platform
- Federal grants#32 · top 28%
- Granted patents#38 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Beth E. DozoretzExecutive Officer, DirectorNamed in SEC Form D filings
- Brad Patrick LucasDirectorNamed in SEC Form D filings
- Gloria E. NussExecutive OfficerNamed in SEC Form D filings
- John E. ChadwickDirectorNamed in SEC Form D filings
- Joseph E. AntonDirectorNamed in SEC Form D filings
- Kip E. OlmsteadExecutive OfficerNamed in SEC Form D filings
Show all 17 people
- Michael I. KofflerExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Rina E. WolfDirectorNamed in SEC Form D filings
- Ronald I. DozoretzExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Scott I. StorrerExecutive Officer, PromoterNamed in SEC Form D filings
- Shawn Patrick O'BrienExecutive Officer, DirectorNamed in SEC Form D filings
- Shelloy Patrick KigerDirectorNamed in SEC Form D filings
- Stacy E. WilliamsExecutive OfficerNamed in SEC Form D filings
- Stephen E. HallerExecutive OfficerNamed in SEC Form D filings
- Theresa E. SextonDirectorNamed in SEC Form D filings
- Thomas E. HessExecutive OfficerNamed in SEC Form D filings
- Tom Patrick HessExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 17- GrantedDisplay Screen With Graphical User InterfaceUSPTOUS D,994,685
- PendingMethods And Systems For Multiplex Allele DetectionUSPTOApplication 17797253
- PendingMethods And Systems For Reporting Patient- And Drug-specific Medical DataUSPTOApplication 17527995
Show all 17 patent records
- Display Screen With Graphical User InterfaceAug 8, 2023 · US D,994,685Granted
- Methods And Systems For Multiplex Allele DetectionFeb 23, 2023 · Application 17797253Pending
- Methods And Systems For Reporting Patient- And Drug-specific Medical DataMay 26, 2022 · Application 17527995Pending
- Detection Of Specific Hla AllelesJan 20, 2022 · Application 17353234Pending
- Systems And Methods For Displaying A Patient Specific ReportDec 23, 2021 · Application 17349797Pending
- Maintenance Therapy Using TianeptineFeb 15, 2018 · Application 15462101Pending
- Methods And Compositions For The Treatment Of Post-traumatic Stress DisorderFeb 2, 2017 · Application 15290961Pending
- Methods For Assessment And Treatment Of Mood Disorders Via Single Nucleotide Polymorphisms AnalysisOct 30, 2014 · Application 14324524Pending
- Methods And Systems For Reporting Patient -and Drug -specific Medical DataApplication PCTUS2021059551Pending
- Methods And Systems For Multiplex Allele DetectionApplication PCTUS2021016570Pending
- Methods And Systems For Reporting Patient- And Drug-specific Medical DataApplication 63117650Pending
- Detection Of Specific Hla AllelesApplication PCTUS2021038236Pending
- Systems And Methods For Identifying And Reporting Genetic Predispositions Associated With Mental Well-beingApplication 63041820Pending
- Systems And Methods Displaying A Patient Specific ReportApplication 63040665Pending
- Maintenance Therapy Using TianeptineApplication 62310425Pending
- Detection Of Specific Hla AllelesApplication 63042902Pending
- Systems And Methods For Identifying And Reporting Genetic Predispositions Associated With Mental Well-beingApplication PCTUS2021038156Pending
Related companies, and why
- Octave Bioscience IncSimilar federal contract value in Medtech · null in contracts
- Scilex Holding CoSimilar federal contract value in Medtech · null in contracts
- Binx HealthSimilar federal contract value in Medtech · null in contracts
- SunBird BioSimilar federal contract value in Medtech · null in contracts
- GI DYNAMICS, INC.Similar federal contract value in Medtech · null in contracts
- Axon Therapies Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .